Skip to content

DR. DEBORAH VAN MELKEBEKE

Active
Private limited companyfounded 2013active for 13 yearsSmetledestraat 22, 9340 Lede, BelgiumKBO/BCE: BE 0541.397.679

From the official registers: KBO 12 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. DEBORAH VAN MELKEBEKE has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €584,766 and a net result of €99,954. Equity has been growing by about 17% per year since 2018. Its solvency ranks better than 78% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 23-10-2013 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.224.474.571 9300 Aalst, since 23-10-2013
Financial year end
31 December
Peppol
Reachable since 28-01-2026

Board and ownership

Board

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€157,790
▲ 6.5%
Turnover
≈ €290,000
estimated
Profit
€99,954
▲ 8.0%
Equity
€584,766
▲ 1.9%
Total assets
€678,293
▲ 3.3%
Filed on 31-07-2026, on timeat the National Bank
Score breakdownraises risk2 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.94, cash €448,779Equity €584,766 (86.2% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 62% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 86.2% of total assets
Liquidity 98=
short-term debt 13.8% · cash 66.2%
Profitability 87+1
return on assets 14.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: 0.1%▲ +0.1 percentage points vs 09-2025highest value 11-2025: < 0.1%▼ -0.1 percentage points vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.94 (7.49 in 2024), above the usual 1.5. Short-term debt is 13.8% and cash 66.2% of total assets. 13.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 86% on liquidity, 39% on profitability and 42% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 2 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.94, cash €448,779
NBB · annual accounts
lowers risk · Equity €584,766 (86.2% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
61 days late
2023
72 days late
2022
32 days late
2021
46 days early
2020
31 days late
2019
66 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 31 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 September (4 of the last 5 accounts filed within 41 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 85% of companies in human healthsector median €124,628 · 20,680 companies €584,766 View
  • Positive: 8 profitable years in a rowprofit 2025: €99,954 8 years View

Comparable companies

These companies have the same main activity as DR. DEBORAH VAN MELKEBEKE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €618,000 and €718,000, founded between 2011 and 2014.

CompanyTotal assetsGross margin
DR. DEBORAH VAN MELKEBEKE Lede€678,293€157,790
Dr. Van Imschoot Bart, gastro-enterologie Maarkedal€707,008€148,915
Dr. Toon Sabbe, Heelkunde Maldegem€717,918€157,610
CABINET DE CARDIOLOGIE DR. P. MELON Liège€687,839€150,804
PALUMBO RADIOTHERAPY TECHNIQUES Fleurus€670,103€172,125
Dr. Aline Berners Wavre€621,393€160,261
Dr. JORDAENS Elsene€617,602€160,846
Full comparison

Documents

Annual accounts at the NBB

All 12 annual accounts

Articles and registers

Key facts about DR. DEBORAH VAN MELKEBEKE

What is the company number of DR. DEBORAH VAN MELKEBEKE?
The company number of DR. DEBORAH VAN MELKEBEKE is 0541.397.679. The VAT number is the same number with BE in front: BE 0541.397.679.
Where is DR. DEBORAH VAN MELKEBEKE based?
The registered office is at Smetledestraat 22, 9340 Lede.Company details
What does DR. DEBORAH VAN MELKEBEKE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. DEBORAH VAN MELKEBEKE?
The legal form of DR. DEBORAH VAN MELKEBEKE is Private limited company (BV).
When was DR. DEBORAH VAN MELKEBEKE founded?
DR. DEBORAH VAN MELKEBEKE was founded on 23-10-2013.
Is DR. DEBORAH VAN MELKEBEKE still active?
Yes, DR. DEBORAH VAN MELKEBEKE is an active enterprise in the KBO register.
What is the turnover of DR. DEBORAH VAN MELKEBEKE?
The turnover in financial year 2025 is ≈ €290,000. This figure is estimated from the gross margin of €157,790 and 43 comparable companies (NACE 86220). It probably lies between €250,000 and €390,000.Financials
Is DR. DEBORAH VAN MELKEBEKE profitable?
In financial year 2025, DR. DEBORAH VAN MELKEBEKE made a profit of €99,954.
Where can I find the annual accounts of DR. DEBORAH VAN MELKEBEKE?
DR. DEBORAH VAN MELKEBEKE filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. DEBORAH VAN MELKEBEKE due?
DR. DEBORAH VAN MELKEBEKE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.